Semaglutide for MASH cirrhosis: a new therapeutic frontier or a false dawn? [PDF]
Zhou XD +5 more
europepmc +1 more source
Incidence and Mortality of Community-Acquired Sepsis or Bacteraemia in Patients With Alcohol-Related Cirrhosis. [PDF]
Stenderup CJ +4 more
europepmc +1 more source
Acute Kidney Injury in Patients With Cirrhosis Exposed to Iodinated Contrast: A Systematic Review and Meta-Analysis. [PDF]
Correa TL +11 more
europepmc +1 more source
Abnormal lipid profiles are associated with markers of impaired fibrinolysis in patients with cirrhosis. [PDF]
Elvers FL +5 more
europepmc +1 more source
Predictive role of blood urea nitrogen to serum albumin ratio (BAR) in all-cause mortality in patients with cirrhosis. [PDF]
Zeng Z, Liu Y, Dou Y, Zhou Y.
europepmc +1 more source
Sarcoidosis-Associated Cirrhosis: Biological Risk or Surveillance Artifact? [PDF]
Feng J, Liu L.
europepmc +1 more source
Recurrent and De Novo Cirrhosis After Liver Transplantation. [PDF]
Rao AK, Rockey DC.
europepmc +1 more source
Steatotic Liver Disease Risk Scores to Predict Cirrhosis and Hepatocellular Carcinoma. [PDF]
Mezzacappa C +5 more
europepmc +1 more source
EASL 2025 indications revisited: phase-specific outcomes with and without nucleos(t)ide analogue therapy in chronic hepatitis B virus infection. [PDF]
Tang S +30 more
europepmc +1 more source
Guideline adherence and expert-rated potential safety concerns in AI-generated dietary advice for patients with cirrhosis: a comparative evaluation of large language models. [PDF]
Liu Q, Liang G, Liu X, Song Y, Wu H.
europepmc +1 more source

